Video

Dr. Anne Suskind on study of surgery for bladder/bowel dysfunction in older adults

Author(s):

Urology Times staff

“We wanted to compare outcomes between nursing home residents and community-dwelling older adults undergoing surgery for bladder and bowel dysfunction,” explains Anne M. Suskind, MD.

Anne M. Suskind, MD, discusses the study, “Comparative outcomes for older adults undergoing surgery for bladder and bowel dysfunction.” Suskind is an associate professor of Urology and Obstetrics, Gynecology, and Reproductive Sciences, and a chief of Neurourology and Female Pelvic Medicine and Reconstructive Surgery at the University of California, San Francisco.

Related Videos
Daniel Kwon, MD, answers a question during a Zoom video interview
Andrew C. Peterson, MD, MPH, answers a question during a Zoom interview
DNA helix | Image Credit: © BillionPhotos.com - stock.adobe.com
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
DNA molecules | Image Credit: © vitstudio - stock.adobe.com
Daniel Kwon, MD, answers a question during a Zoom video interview
Andrew C. Peterson, MD, MPH, answers a question during a Zoom video interview
Related Content
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
December 17th 2024

Sexual QOL improved at 12 months following AUS placement

LeRoy Jones, MD
"I think this is a very important trial, just to bring some importance about patients' worries about being sexually active with urinary incontinence," says LeRoy Jones, MD.
Destigmatizing Urology: Dr. Pruthi discusses mental health
May 23rd 2022

Destigmatizing Urology: Dr. Pruthi discusses mental health

Urology Times staff
“I think we often encourage our patients to share concerns about depression, anxiety, and other mental health conditions, yet are less likely ourselves to seek help due to this issue of stigma,” says Raj S. Pruthi, MD, MHA, FACS.
iTNM may provide comparable safety, efficacy to SNM for OAB, UUI
November 4th 2024

iTNM may provide comparable safety, efficacy to SNM for OAB, UUI

Hannah Clarke
The UUI responder rate was 71.8% among those who received SNM and 71.3% among those who received iTNM.
Dr. Dobberfuhl discusses novel onabotulinumtoxinA treatment for refractory OAB
March 21st 2022

Dr. Dobberfuhl discusses novel onabotulinumtoxinA treatment for refractory OAB

Urology Times staff
“This technique is feasible, it is very well tolerated, and there’s not much of a complication rate, so it appears to be very safe,” says Amy D. Dobberfuhl, MD, MS.
Comparable efficacy seen with single vs. multiple OnabotulinumtoxinA injection sites in OAB
October 24th 2024

Comparable efficacy seen with single vs. multiple OnabotulinumtoxinA injection sites in OAB

Hannah Clarke
At 1 month, the mean decrease in the OAB-Q symptom severity subscale score was -31.2 in the 1-injection cohort vs -39.5 in the 10-injection cohort.
Penile prosthesis implantation patients report easy, natural use at 12 months
October 18th 2024

Penile prosthesis implantation patients report easy, natural use at 12 months

Kevin Kunzmann
Data from a Mayo Clinic study show, despite some reports of discomfort and dissatisfaction, a majority of patients receiving penile prosthesis are satisfied 1 year in.
© 2024 MJH Life Sciences

All rights reserved.